From the publishers of JADPRO

Multiple Myeloma Resource Center

Advertisement
Videos
Interview With Samantha Shenoy, MSN, ACNP-BC: Navigating New Frontiers in CAR-T and Cellular Therapies
Interview With Samantha Shenoy, MSN, ACNP-BC: Navigating New Frontiers in CAR-T and Cellular Therapies
Interview With Samantha Shenoy, MSN, ACNP-BC: Evolving Clinical Models for CAR-T and Bispecific Antibodies in Multiple Myeloma
Interview With Samantha Shenoy, MSN, ACNP-BC: Evolving Clinical Models for CAR-T and Bispecific Antibodies in Multiple Myeloma
Interview With Justina Kiernan, PA-C: Advancing Myeloma Care–New Strategies for Relapsed Disease Management
Interview With Justina Kiernan, PA-C: Advancing Myeloma Care–New Strategies for Relapsed Disease Management
Interview With Justina Kiernan, PA-C: Discussing New Frontiers in Multiple Myeloma Immunotherapy
Interview With Justina Kiernan, PA-C: Discussing New Frontiers in Multiple Myeloma Immunotherapy
Interview with Sara Scott, PharmD, BCOP: Outpatient Protocols and Patient Management of Bispecific Antibodies
Interview with Sara Scott, PharmD, BCOP: Outpatient Protocols and Patient Management of Bispecific Antibodies
Interview with Sara Scott, PharmD, BCOP: Highlights from the 2025 International Myeloma Society Annual Meeting
Interview with Sara Scott, PharmD, BCOP: Highlights from the 2025 International Myeloma Society Annual Meeting
Emerging and Re-emerging Therapeutic Strategies in Multiple Myeloma
Emerging and Re-emerging Therapeutic Strategies in Multiple Myeloma
Innovations in Multiple Myeloma Treatment
Innovations in Multiple Myeloma Treatment
Interview with Ann McNeill, RN, MSN, APN: Bispecific T-Cell Engager Therapy Administration and Management
Interview with Ann McNeill, RN, MSN, APN: Bispecific T-Cell Engager Therapy Administration and Management
Interview with Ann McNeill, RN, MSN, APN: Bispecific T-Cell Engager Therapy Considerations and Collaboration
Interview with Ann McNeill, RN, MSN, APN: Bispecific T-Cell Engager Therapy Considerations and Collaboration
Interview with Danielle Roberts, PA-C: Sequencing of Bispecific Antibodies and CAR T-Cell Therapies
Interview with Danielle Roberts, PA-C: Sequencing of Bispecific Antibodies and CAR T-Cell Therapies
Interview with Danielle Roberts, PA-C: Onboarding APPs New to Multiple Myeloma Practice
Interview with Danielle Roberts, PA-C: Onboarding APPs New to Multiple Myeloma Practice
Interview with Dennis Verducci, MSN, RN, NP-BC, OCN: Evolving Technology and Monitoring of Disease
Interview with Dennis Verducci, MSN, RN, NP-BC, OCN: Evolving Technology and Monitoring of Disease
Interview with Dennis Verducci, MSN, RN, NP-BC, OCN: Real-World Treatment and Transplant Strategies
Interview with Dennis Verducci, MSN, RN, NP-BC, OCN: Real-World Treatment and Transplant Strategies
The New Role of MRD Testing in Trials and Treatments
The New Role of MRD Testing in Trials and Treatments
New Trial Data and the Ever-Changing Treatment Landscape
New Trial Data and the Ever-Changing Treatment Landscape
Interview with Sara Scott, PharmD, BCOP: Evolving Treatment Methods
Interview with Sara Scott, PharmD, BCOP: Evolving Treatment Methods
Interview with Sara Scott, PharmD, BCOP: Role of the Clinical Pharmacist and the Multi-team Approach
Interview with Sara Scott, PharmD, BCOP: Role of the Clinical Pharmacist and the Multi-team Approach
Interview with Mary Steinbach, DNP, APRN: Clinical Trials and the Role of the AP
Interview with Mary Steinbach, DNP, APRN: Clinical Trials and the Role of the AP
Interview with Mary Steinbach, DNP, APRN: Bispecifics vs CAR T-Cell Therapy in Multiple Myeloma Treatment
Interview with Mary Steinbach, DNP, APRN: Bispecifics vs CAR T-Cell Therapy in Multiple Myeloma Treatment
Interview with Amy Pierre, MSN, ANP-BC: Treatment and Care Inequities in Black Patients with Multiple Myeloma
Interview with Amy Pierre, MSN, ANP-BC: Treatment and Care Inequities in Black Patients with Multiple Myeloma
Interview with Amy Pierre, MSN, ANP-BC: Choosing the Best Treatment Option for Your Patient
Interview with Amy Pierre, MSN, ANP-BC: Choosing the Best Treatment Option for Your Patient
Advertisement
Case Studies

Mezigdomide in Triple-Class Relapsed/Refractory Multiple Myeloma

Treatment of Newly Diagnosed Multiple Myeloma

Early Relapsed Multiple Myeloma With Translocation (11;14)

Advertisement
Quizzes
Test your knowledge of mezigdomide in triple-class relapsed/refractory multiple myeloma
Test your knowledge in a newly diagnosed case presented initially as single solitary plasmacytoma
Test your knowledge in a multiply relapsed multiple myeloma case